LTN1
Basic information
Region (hg38): 21:28928144-28992956
Previous symbols: [ "C21orf98", "C21orf10", "ZNF294", "RNF160" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LTN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 66 | 73 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 67 | 8 | 2 |
Variants in LTN1
This is a list of pathogenic ClinVar variants found in the LTN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-28931172-AT-A | Neurodevelopmental disorder | Uncertain significance (Jan 01, 2019) | ||
21-28931273-T-C | not specified | Uncertain significance (Aug 01, 2022) | ||
21-28936584-C-G | not specified | Uncertain significance (Jul 29, 2022) | ||
21-28936658-T-C | not specified | Uncertain significance (Sep 25, 2023) | ||
21-28936670-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
21-28941250-T-C | not specified | Uncertain significance (Nov 17, 2022) | ||
21-28941287-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
21-28941372-T-C | not specified | Uncertain significance (Jul 19, 2023) | ||
21-28943680-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
21-28943746-T-C | not specified | Uncertain significance (Nov 20, 2023) | ||
21-28944401-T-G | not specified | Likely benign (Mar 30, 2024) | ||
21-28944435-A-C | not specified | Uncertain significance (Jun 29, 2023) | ||
21-28944466-G-T | not specified | Uncertain significance (Dec 07, 2023) | ||
21-28944472-T-C | not specified | Uncertain significance (Apr 09, 2024) | ||
21-28944479-T-C | not specified | Likely benign (Aug 13, 2021) | ||
21-28944525-C-G | not specified | Uncertain significance (Oct 30, 2023) | ||
21-28944590-T-C | not specified | Uncertain significance (Mar 04, 2024) | ||
21-28945865-G-A | not specified | Uncertain significance (Mar 21, 2022) | ||
21-28945865-G-T | not specified | Uncertain significance (Aug 08, 2023) | ||
21-28946215-T-C | not specified | Uncertain significance (Nov 08, 2022) | ||
21-28946231-C-A | not specified | Uncertain significance (May 17, 2023) | ||
21-28946239-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
21-28952208-C-T | not specified | Uncertain significance (Oct 24, 2023) | ||
21-28952236-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
21-28953244-G-A | not specified | Uncertain significance (Dec 16, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LTN1 | protein_coding | protein_coding | ENST00000389194 | 30 | 64805 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00840 | 0.992 | 125697 | 0 | 51 | 125748 | 0.000203 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.90 | 738 | 898 | 0.822 | 0.0000444 | 11841 |
Missense in Polyphen | 170 | 277.49 | 0.61264 | 3717 | ||
Synonymous | 0.404 | 319 | 328 | 0.972 | 0.0000165 | 3406 |
Loss of Function | 6.38 | 22 | 85.8 | 0.256 | 0.00000431 | 1165 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000275 | 0.000273 |
Ashkenazi Jewish | 0.000496 | 0.000496 |
East Asian | 0.000333 | 0.000326 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.000241 | 0.000229 |
Middle Eastern | 0.000333 | 0.000326 |
South Asian | 0.000147 | 0.000131 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase component of the ribosome quality control complex (RQC), a ribosome-associated complex that mediates ubiquitination and extraction of incompletely synthesized nascent chains for proteasomal degradation (PubMed:23685075, PubMed:25132172, PubMed:25578875). Ubiquitination leads to VCP/p97 recruitment for extraction and degradation of the incomplete translation product (By similarity). {ECO:0000250|UniProtKB:Q04781, ECO:0000269|PubMed:23685075, ECO:0000269|PubMed:25132172, ECO:0000269|PubMed:25578875}.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.0993
Intolerance Scores
- loftool
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.06
Haploinsufficiency Scores
- pHI
- 0.630
- hipred
- N
- hipred_score
- 0.476
- ghis
- 0.585
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Ltn1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); muscle phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- proteasome-mediated ubiquitin-dependent protein catabolic process;protein autoubiquitination;rescue of stalled ribosome;ribosome-associated ubiquitin-dependent protein catabolic process
- Cellular component
- cytosol;RQC complex
- Molecular function
- protein binding;zinc ion binding;ribosomal large subunit binding;ubiquitin protein ligase activity